Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hims & Hers Health ( (HIMS) ) just unveiled an announcement.
On May 18, 2026, Hims & Hers Health, Inc. announced a proposed private offering of $300 million in convertible senior notes due 2032, with an option for initial purchasers to buy an additional $45 million, targeting qualified institutional buyers under Rule 144A. The company also disclosed the structure of the notes, including their senior unsecured status, conversion rights into Class A common stock, redemption provisions from June 2029, and investor protections in the event of a fundamental change.
The net proceeds are intended to support Hims & Hers’ international expansion strategy, including its proposed acquisition of Eucalyptus expected to close in mid-2026, and to fund investments in technology, fulfillment infrastructure, and AI capabilities to improve cost efficiencies and consumer experience. Hims & Hers also plans capped call transactions to limit potential dilution and manage cash exposure on note conversions, a move that could influence trading dynamics in its Class A shares and underscores the company’s effort to balance growth financing with shareholder impact.
The most recent analyst rating on (HIMS) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Hims & Hers Health stock, see the HIMS Stock Forecast page.
Spark’s Take on HIMS Stock
According to Spark, TipRanks’ AI Analyst, HIMS is a Neutral.
The score is driven primarily by strong growth and cash generation, but tempered by materially higher balance-sheet leverage and weakened GAAP profitability. The latest earnings call was a positive offset due to raised guidance and strong GLP-1 traction, while technicals are mixed/soft and valuation is pressured by a negative P/E and no dividend.
To see Spark’s full report on HIMS stock, click here.
More about Hims & Hers Health
Hims & Hers Health, Inc. is a leading health and wellness platform focused on helping consumers improve their well-being through accessible, technology-enabled healthcare services. The company emphasizes digital delivery, a closed-loop data ecosystem, and AI-driven tools to enhance the consumer experience and drive efficiency across its operations.
Average Trading Volume: 36,322,182
Technical Sentiment Signal: Hold
Current Market Cap: $5.71B
For detailed information about HIMS stock, go to TipRanks’ Stock Analysis page.